GlobeNewswire Inc | Jan 7, 2022 08:30AM EST

January 07, 2022

BOCA RATON, Fla., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (Clever Leaves or the Company), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the 2022 ICR Conference, which is being held virtually from January 10-12, 2022.

Clever Leaves management is scheduled to present on Monday, January 10th at 8:30am ET. The presentation will be webcast live and available for replay here and via the Events section of the Companys website here.

To receive additional information, request an invitation or schedule a one-on-one meeting with Clever Leaves management, please contact your ICR representative or the Companys investor relations team at CLVR@gatewayir.com.

About Clever Leaves Holdings Inc.

Clever Leaves is a multinational cannabis company with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade cannabinoid processing as the cornerstones of its global cannabis business. With operations and investments in the United States, Canada, Colombia, Germany and Portugal, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industrys leading global cannabis companies recognized for its principles, people, and performance while fostering a healthier global community. Clever Leaves has received multiple international certifications that have enabled it to increase its export and sales capacity from its Colombian operations, including European Union Good Manufacturing Practices (EU GMP) Certification, a Good Manufacturing Practices (GMP) Certification by Colombia National Food and Drug Surveillance Institute - Invima, and Good Agricultural and Collecting Practices (GACP) Certification. Clever Leaves was granted a license in Portugal from INFARMED the Portuguese health authority which allows Clever Leaves to cultivate, import and export dry flower for medicinal and research purposes. In addition, the Portuguese operation was also granted certification of compliance with GACP and IMC-GAP. For more information, visit https://cleverleaves.com/en/home/ and follow Clever Leaves on Twitter and LinkedIn.

Clever Leaves Investor Inquiries:Cody Slach or Jackie KeshnerGateway Investor Relations+1-949-574-3860CLVR@gatewayir.com

Clever Leaves Press Contacts:McKenna MillerKCSA Strategic Communications+1-347-487-6197mmiller@kcsa.com

Diana SigenzaStrategic Communications Director+57-310-236-8830diana.siguenza@cleverleaves.com

Clever Leaves Commercial Inquiries:Andrew MillerVice President Sales - EMEA, North America, and Asia-Pacific+1-416-817-1336andrew.miller@cleverleaves.com